Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

[1]  R. Riffenburgh,et al.  Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[2]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[3]  M. Kahn,et al.  A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma , 1997, Cancer.

[4]  H. Levin,et al.  Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  F. Vicini,et al.  The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[6]  D. Kuban,et al.  Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. , 1999, JAMA.

[7]  E. Bergstralh,et al.  Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. , 2000, The Journal of urology.

[8]  C. Reddy,et al.  Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. , 2000, Urology.

[9]  M W Kattan,et al.  Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Kattan,et al.  Year of treatment is an independent predictor of outcome in patients with localized prostate cancer treated with definitive radiotherapy , 2001 .

[11]  A W Partin,et al.  Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. , 2001, The Journal of urology.

[12]  A. Partin,et al.  Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.

[13]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[14]  B. Trock,et al.  A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. , 2002, The Journal of urology.

[15]  A. Zietman,et al.  Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  The hazards of dose escalation in prostate cancer radiation , 2002 .

[17]  F. Critz.  A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition. , 2002, The Journal of urology.

[18]  A. Renshaw,et al.  Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. , 2002, International journal of radiation oncology, biology, physics.

[19]  Performing daily prostate targeting with a standard V-EPID and an automated radio-opaque marker detection algorithm , 2002 .

[20]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[21]  F. Vicini,et al.  Practical application of biochemical failure definitions: what to do and when to do it. , 2001, International journal of radiation oncology, biology, physics.

[22]  C. Reddy,et al.  Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. , 2003, International journal of radiation oncology, biology, physics.

[23]  D. Kuban,et al.  Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. , 2003, International journal of radiation oncology, biology, physics.